Child and adolescent psychiatric clinics of North America
-
Child Adolesc Psychiatr Clin N Am · Oct 2019
ReviewPsychotropic Medication for Children and Adolescents with Eating Disorders.
Psychotropic medications are commonly used in the treatment of eating disorders in children and adolescents. This article reviews the evidence base on psychotropic medications, including all randomized trials, uncontrolled trials, and case reports for the treatment of anorexia nervosa, bulimia nervosa, other specified feeding and eating disorders, binge-eating disorder, and avoidant/restrictive food intake disorder. Despite advances in the number of medication-based studies completed in young patients with eating disorders over the last 2 decades, significantly more work needs to be done in terms of identifying what role, if any, psychotropic medications can have on treatment outcomes.
-
Child Adolesc Psychiatr Clin N Am · Apr 2019
Where Do We Go from Here? Additional Opportunities to Address Well-Being in Child Psychiatry Clinical Practice and Advocacy for Children and Families.
Child psychiatrists should play an active role in helping parents and children to develop healthy media use habits and can introduce uses of technology including mobile applications and telepsychiatry to enhance clinical care. Strength-based approaches in clinical assessment and treatment build patient and family engagement and enhance outcomes in child psychiatry. Focusing on supporting youths' strengths and enhancing emotional and behavioral well-being are critical strategies for child psychiatrists working in consultation with schools and other community settings, and in advocating for optimal environments for children and families.
-
Child Adolesc Psychiatr Clin N Am · Jul 2018
Crisis in the Emergency Department: The Evaluation and Management of Acute Agitation in Children and Adolescents.
Acute agitation in children and adolescents in the emergency department carries significant risks to patients and staff and requires skillful management, using both nonpharmacologic and pharmacologic strategies. Effective management of agitation requires understanding and addressing the multifactorial cause of the agitation. ⋯ Nonpharmacologic deescalation strategies should be first line for preventing and managing agitation and should continue during and after medication administration. Choice of medication should focus on addressing the cause of the agitation and any underlying psychiatric syndromes.
-
Child Adolesc Psychiatr Clin N Am · Apr 2018
ReviewInattention to Problematic Media Use Habits: Interaction Between Digital Media Use and Attention-Deficit/Hyperactivity Disorder.
As digital media (DM) access among youths continues to surge, caregivers and clinicians are concerned about problems associated with its excessive use. Children with attention-deficit/hyperactivity disorder (ADHD) have an increased risk of experiencing negative effects on sleep, academic achievement, attention, and cognitive skills. ADHD symptom severity and circumstances of DM access are among the factors that mediate these negative effects. Key interventions for parents and clinicians to assist youths with problematic DM habits and opportunities for advocacy groups and the DM industry for public health interventions are discussed.
-
Opioid use and addiction in adolescents and young adults is a health problem of epidemic proportions, with devastating consequences for youth and their families. Opioid overdose is a life-threatening emergency that should be treated with naloxone, and respiratory support if necessary. ⋯ Treatment for OUDs is effective but treatment capacity is alarmingly limited and under-developed. Emerging consensus supports the incorporation of relapse prevention medications such as buprenorphine and extended release naltrexone into comprehensive psychosocial treatment including counseling and family involvement.